홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Sodium Chloride → (r)-5,11-Dihydro-5-[1-(4-pyrrolidinophenethyl)pyrrolidin-3-yl]dibenzo[b,e][1,4]oxazepine

HRID 2251904
인쇄

반응식

HRID 2251904 반응식
[H-].[Na+].[CH:3]1[C:13]2[CH2:12][O:11][C:10]3[CH:14]=[CH:15][CH:16]=[CH:17][C:9]=3[NH:8][C:7]=2[CH:6]=[CH:5][CH:4]=1.CS(O[C@H:23]1[CH2:27][CH2:26][N:25]([CH2:28][CH2:29][C:30]2[CH:35]=[CH:34][C:33]([N:36]3[CH2:40][CH2:39][CH2:38][CH2:37]3)=[CH:32][CH:31]=2)[CH2:24]1)(=O)=O.[Cl-].[Na+]>CCCCCC.CS(C)=O.C(OCC)(=O)C>[N:36]1([C:33]2[CH:34]=[CH:35][C:30]([CH2:29][CH2:28][N:25]3[CH2:26][CH2:27][C@@H:23]([N:8]4[C:7]5[CH:6]=[CH:5][CH:4]=[CH:3][C:13]=5[CH2:12][O:11][C:10]5[CH:14]=[CH:15][CH:16]=[CH:17][C:9]4=5)[CH2:24]3)=[CH:31][CH:32]=2)[CH2:40][CH2:39][CH2:38][CH2:37]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 4

HCID 5234Sodium ChlorideHCID 24758Sodium hydrideHCID 110847985,11-Dihydrodibenzo[b,e][1,4]oxazepineHCID 59643988(S)-3-methanesulfonyloxy-1-(4-pyrrolidinophenethyl)pyrrolidine

생성물 1

HCID 12990605(r)-5,11-Dihydro-5-[1-(4-pyrrolidinophenethyl)pyrrolidin-3-yl]dibenzo[b,e][1,4]oxazepine

시약·촉매·용매 3

HCID 679
Dimethyl Sulfoxide
용매
2회
HCID 8058Hexane용매
HCID 8857Ethyl Acetate용매

실험 절차

60% sodium hydride (132 mg, 3.3 mmol) was washed with hexane in argon stream and then suspended in dimethyl sulfoxide (10 ml), and the obtained suspension was stirred at room temperature for 30 minutes. 5,11-Dihydrodibenzo[b,e][1,4]oxazepine (600 mg, 3.0 mmol) was added to the suspension, and they were stirred at room temperature for 30 minutes and then at 50° C. for additional 30 minutes. A solution of (S)-3-methanesulfonyloxy-1-(4-pyrrolidinophenethyl)pyrrolidine (340 mg, 1.0 mmol) in dimethyl sulfoxide (5 ml) was added dropwise to the obtained solution, and they were stirred at 50° C. for 42 hours. The reaction mixture was distributed into saturated aqueous sodium chloride solution and ethyl acetate. The organic layer was dried and the solvent was evaporated under reduced pressure. The residue was subjected to the silica gel column chromatography. After the elution with hexane and ethyl acetate (3:1), suitable fractions were collected and the solvent was evaporated under reduced pressure to obtain (R)-5,11-dihydro-5-[1-(4-pyrrolidinophenethyl)pyrrolidin-3-yl]dibenzo[b,e][1,4]oxazepine in the form of a light yellow oily substance (142 mg, 32%).

후처리

  1. stirringwere stirred at room temperature for 30 minutes
  2. waitat 50° C. for additional 30 minutes
  3. stirringwere stirred at 50° C. for 42 hours
  4. customThe organic layer was dried
  5. customthe solvent was evaporated under reduced pressure
  6. washAfter the elution with hexane and ethyl acetate (3:1), suitable fractions
  7. customwere collected
  8. customthe solvent was evaporated under reduced pressure

출처 및 근거

ORD 기록
ord-9c06b4d3850740a29ca4d2cc70dd5443
출처 데이터셋
uspto-grants-2008_01
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07320973B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트